Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction
Giancarlo Marenzi, MD*,
Gianfranco Lauri, MD,
Emilio Assanelli, MD,
Jeness Campodonico, MD,
Monica De Metrio, MD,
Ivana Marana, MD,
Marco Grazi, MD,
Fabrizio Veglia, PhD and
Antonio L. Bartorelli, MD, FACC
Centro Cardiologico Monzino, I.R.C.C.S., Institute of Cardiology of the University of Milan, Milan, Italy
View larger version (12K):
[in a new window]
|
Figure 1 Median and interquartile ranges of serum creatinine concentration in patients developing (squares) and in those not developing (circles) contrast-induced nephropathy after primary angioplasty. Data are shown at baseline, during the following three days, and at discharge from the coronary care unit (CCU).
|
|
View larger version (11K):
[in a new window]
|
Figure 2 Incidence of contrast-induced nephropathy (CIN) in study patients according to the risk score. p < 0.0001.
|
|
View larger version (11K):
[in a new window]
|
Figure 3 Incidence of in-hospital death in study patients according to the risk score. p < 0.0001.
|
|
|
